InspireMD (NSPR) announced the appointment of Raymond W. Cohen to its Board of Directors. Until May of 2025, Mr. Cohen served as Chairman of SoniVie, a clinical stage company focused on a device treatment for hypertension until it was acquired by Boston Scientific for $600 million.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSPR: